Proceedings of the 2024 North American Society of Head and Neck Pathology Companion Meeting, Baltimore, MD, March 24, 2024: Navigating Ancillary Studies in Basaloid/Blue Salivary Tumors

BackgroundBasaloid salivary tumors can demonstrate significant morphologic overlap and be challenging to diagnose.MethodsA review of select ancillary studies in basaloid salivary tumors was performed.ResultsA number of immunohistochemical stains, including PLAG1, HMGA2, beta-catenin, MYB, and RAS Q61R, have been more recently incorporated into the diagnostic workup of basaloid salivary tumors.ConclusionsAlthough reported variability in their performance has perhaps limited their widespread adoption, these immunohistochemical studies can nevertheless be useful in supporting pathologic diagnoses, particularly when considered in more specific differentials or when used as a panel with other markers.